.png)
Haier Biomedical News
Synthetic DNA shaping the future of biomanufacturing
Touchlight is a biotechnology company bringing DNA production into the future with its proprietary synthetic DNA vector, doggybone DNA (dbDNATM). By moving beyond the constraints of biological processes, this innovative approach allows the company to produce high- purity DNA at greater scale and speed, meeting the growing demand for personalised medicines. James Johnson, Head of Maintenance and Calibration at Touchlight, oversees the integration of lab equipment, ensuring the success of the company’s GMP (good manufacturing practice) facilities and production processes.
A Decade in the UK: People, Partnerships and Progress
Haier Biomedical sets a new benchmark for smart, secure LN2 storage
Reflections on Our First SinS Conference Experience
Attending the Science in Separation (SinS) conference marked a significant milestone for us at Haier Biomedical. It was our very first time engaging with professionals from across the Analytical Sciences community—and what an insightful introduction it was.
Now Available: UV/Visible Spectrophotometers from Haier Biomedical
Haier Biomedical UK is proud to announce the expansion of our laboratory equipment range with the launch of a new portfolio of UV/Visible Spectrophotometers, building on Haier’s strategic acquisition of analytical instrument manufacturer Metash Instruments.
Beyond the Miles: Why Every Kilometre Doesn’t Count the Same
Laboratories are under increasing pressure to reduce their environmental impact—but when it comes to assessing the sustainability of lab equipment, location isn't everything.
A new whitepaper from Haier Biomedical reveals why evaluating the green credentials of scientific instruments goes far beyond simply measuring distance from the manufacturer. It’s time to rethink how we define “eco-friendly” procurement.
.png)
Haier Biomedical sets new standard for energy efficient ULT storage
End of Term Lab Equipment Offers – While Stocks Last!
.png)
